CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Revenues:
Total revenues	$ 102,660	$ 40,813	$ 180,995	$ 68,427
Operating expenses:
Research and development	15,594	12,319	30,003	24,385
Selling, general and administrative	103,013	58,792	188,008	110,370
Total operating expenses	124,844	74,115	229,459	139,413
Loss from operations before other income (expense)	(22,184)	(33,302)	(48,464)	(70,986)
Other income (expense):
Interest income	4,229	4,130	7,683	7,247
Interest expense	(2,240)	(2,109)	(4,453)	(3,092)
Loss on debt extinguishment	0	(1,944)	0	(1,944)
Other income (expense), net	(145)	(65)	(226)	(246)
Total other income (expense), net	1,844	12	3,004	1,965
Net loss	(20,340)	(33,290)	(45,460)	(69,021)
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Unrealized gain (loss) on marketable securities and cash equivalents	(46)	(113)	(140)	(174)
Comprehensive loss	$ (20,386)	$ (33,403)	$ (45,600)	$ (69,195)
Net loss per share - basic (usd per share)	$ (0.48)	$ (0.88)	$ (1.11)	$ (1.89)
Net loss per share - diluted (usd per share)	$ (0.48)	$ (0.88)	$ (1.11)	$ (1.89)
Weighted-average shares outstanding, basic (in shares)	42,360,452	37,823,233	40,869,364	36,530,756
Weighted-average shares outstanding - diluted (in shares)	42,360,452	37,823,233	40,869,364	36,530,756
Product sales, net
Revenues:
Total revenues	$ 102,660	$ 40,813	$ 180,995	$ 65,533
Operating expenses:
Cost of sales	6,237	3,004	11,448	4,658
License fees and collaboration revenue
Revenues:
Total revenues	$ 0	$ 0	$ 0	$ 2,894